Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 2.32 Billion | USD 4.42 Billion | 7.4% | 2023 |
The global smart implantable pumps market size was worth around USD 2.32 billion in 2023 and is predicted to grow to around USD 4.42 billion by 2032 with a compound annual growth rate (CAGR) of roughly 7.4% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the smart implantable pumps market on a global and regional level.
Implantable pumps or infusion pumps are small-sized medical devices that are implanted into the human body for delivering drugs and administer their steady doses. The implantable pumps function on the reservoir mechanism that is placed medically inside the human body, which is attached with a thin flexible tube. The pump delivers the drug through this flexible tube to a specific body part. The implantable pumps aim to serve drug infusion through the intra-arterial route for a long period of time. The integration of smart technology in the implantable pumps is called smart implantable pumps. The advantages of these pumps include the elimination of drug overdosing, drug delivery without any biological obstacle, and administration of drug doses conveniently.
The rising prevalence of chronic diseases, such as cancer, diabetes, and pain associated with them, is the key factor projected to drive the growth of the global smart implantable pumps market in the future. Moreover, the increasing geriatric population base, rising health consciousness of people, growing healthcare expenditures in developing countries, favorable reimbursement policies, and government support to avail the best patient treatment options are propelling the global smart implantable pumps market. However, stringent regulatory strategies for the approval of smart implantable pumps and rising number of product recalls due to medicine errors of infusion pumps may obstruct the smart implantable pumps market growth.
The study provides a decisive view of the smart implantable pumps market is categorized based on type, application, end-user, and region.
On the basis of type, the global smart implantable pumps market includes micro-pumps and perfusion pumps.
By application, the smart implantable pumps market is categorized into cardiovascular and pain and spasticity. The cardiovascular segment accounted for the largest share in the global smart implantable pumps market in 2023, due to the growing prevalence of hormonal disorders, such as diabetes.
Based on end-user, the smart implantable pumps market includes ambulatory surgical centers, hospitals, and others.
Report Attributes | Report Details |
---|---|
Report Name | Smart Implantable Pumps Market |
Market Size in 2023 | USD 2.32 Billion |
Market Forecast in 2032 | USD 4.42 Billion |
Growth Rate | CAGR of 7.4% |
Number of Pages | 120 |
Key Companies Covered | Abbott, Flowonix Medical, Berlin Heart, Tricumed Medizintechnik, and Medtronic |
Segments Covered | By type, By application, By end-user and By region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segment includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa.
North America and Europe are estimated to account for major shares in the smart implantable pumps market globally. This can be due to the rising cardiovascular diseases cases in the U.S. and the growing number of ambulatory surgical centers and hospitals leading to increased use of infusion pump in these regions. The Asia Pacific is expected to register the highest growth in the global smart implantable pumps market over the forecast time period, growing healthcare infrastructure, increasing government support, and rising regional awareness about newer medical devices.
Some major players operating in the global smart implantable pumps market are:
Global Smart Implantable Pumps Market: Type Analysis
Global Smart Implantable Pumps Market: Application Analysis
Global Smart Implantable Pumps Market: End-User Analysis
Global Smart Implantable Pumps Market: Regional Analysis
FrequentlyAsked Questions
Smart implantable pumps are advanced medical devices designed to deliver medications or fluids directly into the body with precision and control.
According to study, the Smart Implantable Pumps market size was worth around USD 2.32 billion in 2023 and is predicted to grow to around USD 4.42 billion by 2032.
The CAGR value of Smart Implantable Pumps market is expected to be around 7.4% during 2024-2032.
North America and Europe has been leading the Smart Implantable Pumps market and is anticipated to continue on the dominant position in the years to come.
The Smart Implantable Pumps market is led by players like Abbott, Flowonix Medical, Berlin Heart, Tricumed Medizintechnik, and Medtronic.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed